12.24
price down icon0.66%   -0.0839
 
loading

Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie

pulisher
11:25 AM

How hedge fund analytics apply to Ocular Therapeutix Inc. stockJuly 2025 Catalysts & Entry and Exit Point Strategies - Newser

11:25 AM
pulisher
11:19 AM

Has Ocular Therapeutix Inc. found a price floorMarket Trend Report & Capital Efficiency Focused Strategies - Newser

11:19 AM
pulisher
07:00 AM

Ocular Therapeutix™ to Participate in September Investor and Scientific Conferences - Yahoo Finance

07:00 AM
pulisher
06:27 AM

Statistical indicators supporting Ocular Therapeutix Inc.’s strengthWeekly Trade Review & Free High Accuracy Swing Entry Alerts - Newser

06:27 AM
pulisher
06:26 AM

News impact scoring models applied to Ocular Therapeutix Inc.2025 Retail Activity & Long-Term Safe Investment Plans - Newser

06:26 AM
pulisher
05:30 AM

Ocular Therapeutix Drops 10.71% on Earnings Miss - AInvest

05:30 AM
pulisher
03:14 AM

Visual trend scoring systems applied to Ocular Therapeutix Inc.Gap Down & Expert Approved Trade Ideas - Newser

03:14 AM
pulisher
03:10 AM

Historical volatility pattern of Ocular Therapeutix Inc. visualizedShort Setup & Weekly Chart Analysis and Guides - Newser

03:10 AM
pulisher
01:17 AM

Is Ocular Therapeutix Inc. stock poised for growthJuly 2025 Market Mood & Weekly Setup with High ROI Potential - Newser

01:17 AM
pulisher
12:50 PM

Is it time to cut losses on Ocular Therapeutix Inc.Earnings Beat & Technical Buy Zone Confirmation - Newser

12:50 PM
pulisher
Aug 26, 2025

Best data tools to analyze Ocular Therapeutix Inc. stockJuly 2025 Momentum & Fast Gain Swing Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Ocular Therapeutix Inc. stock trend outlook and recovery pathPortfolio Risk Report & Comprehensive Market Scan Insights - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Chart based analysis of Ocular Therapeutix Inc. trendsJuly 2025 Highlights & AI Forecast Swing Trade Picks - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

What high frequency data says about Ocular Therapeutix Inc.July 2025 Final Week & Capital Protection Trading Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Ocular Therapeutix Inc. stock retracement – recovery analysisEarnings Overview Report & Safe Investment Capital Preservation Plans - Newser

Aug 26, 2025
pulisher
Aug 25, 2025

Quantitative breakdown of Ocular Therapeutix Inc. recent moveShare Buyback & Consistent Return Strategy Ideas - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Ocular Therapeutix Inc. Rebound Backed by Sentiment Shift2025 Fundamental Recap & Free Accurate Trade Setup Notifications - classian.co.kr

Aug 25, 2025
pulisher
Aug 23, 2025

What are Ocular Therapeutix Inc.’s earnings expectationsJuly 2025 Retail & AI Enhanced Trading Signals - theviewers.co.kr

Aug 23, 2025
pulisher
Aug 23, 2025

Using Bollinger Bands to evaluate Ocular Therapeutix Inc.July 2025 Breakouts & Real-Time Volume Analysis - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

Is There Enough Volume to Lift Ocular Therapeutix Inc.Market Trend Summary & Precise Buy Zone Identification - 더경남뉴스

Aug 23, 2025
pulisher
Aug 23, 2025

Backtesting results for Ocular Therapeutix Inc. trading strategiesWeekly Trade Analysis & High Accuracy Investment Entry Signals - Newser

Aug 23, 2025
pulisher
Aug 20, 2025

Ocular Therapeutix Inc. Shows Support at Fibonacci LevelJuly 2025 Outlook & Weekly High Conviction Ideas - newsyoung.net

Aug 20, 2025
pulisher
Aug 20, 2025

Ocular Therapeutix Inc. Stock Poised for Technical ComebackJuly 2025 Closing Moves & Weekly Top Stock Performers List - mustnews.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

Does Ocular Therapeutix Inc. fit your quant trading model2025 Historical Comparison & AI Based Buy and Sell Signals - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Is Ocular Therapeutix Inc. stock bottoming outTrade Risk Report & Community Consensus Stock Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Can swing trading help recover from Ocular Therapeutix Inc. lossesStock Surge & AI Driven Price Predictions - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Has Ocular Therapeutix Inc. Stock Ever Crashed Historical Volatility ReviewMarket Activity Summary & Fast Moving Market Watchlists - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

What makes Ocular Therapeutix Inc. stock price move sharply2025 Price Momentum & Breakout Confirmation Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Using data filters to optimize entry into Ocular Therapeutix Inc.Portfolio Return Report & Low Drawdown Trading Strategies - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Ocular gets FDA agreement for registrational trial of Axpaxl - MSN

Aug 17, 2025
pulisher
Aug 16, 2025

Quant Strategy Flags Ocular Therapeutix Inc. for EntryJuly 2025 Earnings & Community Consensus Picks - newsyoung.net

Aug 16, 2025
pulisher
Aug 16, 2025

What earnings revisions data tells us about Ocular Therapeutix Inc.July 2025 Drop Watch & Community Shared Stock Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Momentum divergence signals in Ocular Therapeutix Inc. chartPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Ocular Therapeutix receives FDA agreement under SPA for registrational trial of AXPAXLI in NPDR - Eyes On Eyecare

Aug 15, 2025
pulisher
Aug 15, 2025

FDA agrees to SPA for Ocular Therapeutix NPDR registrational trial - Eyes On Eyecare

Aug 15, 2025
pulisher
Aug 14, 2025

Ocular Therapeutix at H.C. Wainwright: Strategic Moves in Eye Care By Investing.com - Investing.com Canada

Aug 14, 2025
pulisher
Aug 13, 2025

Ocular Therapeutix receives FDA agreement under special protocol assessment for registrational trial of AXPAXLI - Ophthalmology Times

Aug 13, 2025
pulisher
Aug 12, 2025

Ocular Therapeutix™ Receives FDA Agreement Under Special - GlobeNewswire

Aug 12, 2025
pulisher
Aug 12, 2025

Ocular Therapeutix: Strategic Advancements and Market Potential Drive Buy Rating - TipRanks

Aug 12, 2025
pulisher
Aug 12, 2025

Ocular Therapeutix's AXPAXLI: A Game-Changer in Diabetic Retinopathy and Wet AMD Markets - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Ocular Therapeutix Receives FDA Agreement for Axpaxl Trial in NPDR Treatment - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Ocular Therapeutix secures FDA agreement for diabetic retinopathy trial By Investing.com - Investing.com Australia

Aug 12, 2025
pulisher
Aug 12, 2025

Ocular Therapeutix secures FDA agreement for diabetic retinopathy trial - Investing.com

Aug 12, 2025
$24.78
price up icon 1.00%
$84.78
price up icon 0.95%
$24.90
price down icon 7.62%
$102.23
price down icon 2.31%
$133.66
price up icon 1.12%
biotechnology ONC
$298.85
price down icon 3.37%
Capitalizzazione:     |  Volume (24 ore):